Carbon dioxide desorption

Carbon dioxide desorption is the physiological process by which dissolved carbon dioxide (CO2) is released from the liquid phase of the blood into the gaseous phase within the pulmonary alveoli for elimination from the body (StatPearls, NBK532988). This process is a critical component of external respiration and is essential for maintaining acid-base homeostasis and regulating blood pH (StatPearls, NBK532988). In the blood, the majority of CO2 is transported as bicarbonate; the conversion of this bicarbonate back into gaseous CO2 is rapidly catalyzed by the enzyme carbonic anhydrase located in red blood cells and pulmonary capillary endothelium (StatPearls, NBK557736). While carbon dioxide desorption is a fundamental biological event, it is classified as a physical-chemical process rather than a discrete therapeutic target such as a receptor or enzyme. Pharmacological modulation of this process is typically achieved through the use of carbonic anhydrase inhibitors, which are used to treat conditions like glaucoma, altitude sickness, and certain types of edema by altering the rate of CO2/bicarbonate interconversion (PubChem, CID 1986). Consequently, identifying 'Carbon dioxide desorption' as a target molecule is technically incorrect, as it refers to a mechanism of gas exchange rather than a specific molecular structure.

Other names

CO2 desorptionCarbon dioxide degassingCO2 releasePulmonary CO2 elimination

Drugs do not target the desorption process directly; instead, they inhibit the enzyme carbonic anhydrase, which catalyzes the hydration and dehydration of carbon dioxide, thereby slowing the conversion of bicarbonate to gaseous CO2 and impacting the rate of desorption in the lungs and kidneys (StatPearls, NBK557736).